Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Mylan

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mylan's 2012 sales performance.

Mylan Inc.

CHMP recommends eight new medicines for EU approval

CHMP recommends eight new medicines for EU approval

Two generic medicines also received positive opinions from the CHMP: Abiraterone Mylan (abiraterone acetate), a generic of Janssen’s Zytiga, for the treatment of metastatic prostate cancer and Fingolimod Mylan (fingolimod),

Teva reaches $925,000 settlement to resolve drug price-fixing claims

Teva reaches $925,000 settlement to resolve drug price-fixing claims Teva was among a group of 20 pharma companies cited in the lawsuit, alongside Novartis’ Sandoz Unit, Mylan, Pfizer and others.

Back to the future

Back to the future business. The ancestors of these business model genera could already be seen in, for example, Roche, Mylan and Fresenius but in each case we have seen increasing specialisation and, consequently, differentiation.

Pfizer's basic instincts

Pfizer's basic instincts It happened to coincide with a blizzard of emails from friends who work for parts of Pfizer or for Mylan and now have Viatris.com addresses. ... At the same time, the welding of Mylan and Pfizer’s Upjohn business was accompanied with press release

New intramuscular administration for Biogen’s MS therapy Plegridy approved in the EU

New intramuscular administration for Biogen’s MS therapy Plegridy approved in the EU The Patent Trial and Appeal Board – run by the US Patent and Trademark Office – determined that Mylan did not sufficiently demonstrate its claim and dismissed the challenge. ... Circuit to remove this patent from blocking generic competition to

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...